| P50 | author | Iris Zeller | Q83379126 |
| | Birgit Willinger | Q89285388 |
| | Kathrin Spettel | Q89689851 |
| P2093 | author name string | Peter-Michael Rath | |
| | Athanasios Makristathis | |
| | Joerg Steinmann | |
| | Marion Nehr | |
| | Wolfgang Barousch | |
| | Michaela Lackner | |
| | Brigitte Selitsch | |
| P2860 | cites work | A rapid method for isolation of genomic DNA from food-borne fungal pathogens. | Q54016201 |
| | Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans. | Q54073912 |
| | The mutation T315A in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity | Q73084701 |
| | Investigation of mutations in Erg11 gene of fluconazole resistant Candida albicans isolates from Turkish hospitals | Q84517255 |
| | Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing | Q36870777 |
| | Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system. | Q37301949 |
| | Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. | Q37374850 |
| | Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria | Q38916677 |
| | Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. | Q39279261 |
| | Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species | Q39388869 |
| | Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence | Q39606039 |
| | A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility | Q39686624 |
| | Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. | Q39899742 |
| | Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis. | Q40166236 |
| | ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates | Q40562539 |
| | Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance | Q40738359 |
| | Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance | Q41184732 |
| | Next-generation sequencing offers new insights into the resistance of Candida spp. to echinocandins and azoles. | Q41199783 |
| | Infectious Disease. How to bolster the antifungal pipeline | Q41378447 |
| | Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility | Q41957394 |
| | Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans. | Q41990022 |
| | FKS Mutations and Elevated Echinocandin MIC Values among Candida glabrata Isolates from U.S. Population-Based Surveillance | Q42250085 |
| | Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1 | Q42408700 |
| | Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint | Q42545839 |
| | Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans | Q43102358 |
| | Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria | Q43125888 |
| | Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans | Q47940968 |
| | A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers | Q21266698 |
| | Epidemiology and risk factors for invasive candidiasis | Q27024911 |
| | Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence | Q27318203 |
| | Fast gapped-read alignment with Bowtie 2 | Q27860699 |
| | Guidelines for investigating causality of sequence variants in human disease | Q28655218 |
| | Trimmomatic: a flexible trimmer for Illumina sequence data | Q29547278 |
| | Primer3--new capabilities and interfaces | Q29614816 |
| | The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data | Q31136511 |
| | Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing | Q33493582 |
| | TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. | Q33559776 |
| | Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance | Q33805788 |
| | Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata | Q33847058 |
| | Breakthrough invasive Candida glabrata in patients on micafungin: a novel FKS gene conversion correlated with sequential elevation of MIC. | Q33900103 |
| | VarScan: variant detection in massively parallel sequencing of individual and pooled samples | Q34018143 |
| | Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates | Q34045265 |
| | Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants | Q34510712 |
| | A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans | Q34588684 |
| | New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species | Q35139501 |
| | Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans | Q35757564 |
| | Topological and mutational analysis of Saccharomyces cerevisiae Fks1 | Q36156130 |
| | Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations | Q36856930 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | massive parallel sequencing | Q6784807 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida glabrata | Q139137 |
| | Candida albicans | Q310443 |
| P304 | page(s) | e0210397 | |
| P577 | publication date | 2019-01-10 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing | |
| P478 | volume | 14 | |